Drug Type ASO  | 
Synonyms ION 440  | 
Target  | 
Action modulators  | 
Mechanism MECP2 modulators(Methyl-CpG-binding protein 2 modulators)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePhase 1/2  | 
First Approval Date-  | 
RegulationOrphan Drug (United States)  | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Lubs X-Linked Mental Retardation Syndrome | Phase 2 | United States   | 21 Oct 2024 | |
| Lubs X-Linked Mental Retardation Syndrome | Phase 2 | France   | 21 Oct 2024 | 





